Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 First in Human Study of ARV-393 in Adult Participants With Advanced Non-Hodgkin's Lymphoma

NCT06393738 is registered in ClinicalTrials.gov with Arvinas Inc. as lead sponsor.

NCT NCT06393738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06393738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 First in Human Study of ARV-393 in Adult Participants With Advanced Non-Hodgkin's Lymphoma
Lead sponsor
Arvinas Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
September 5, 2024
Completion date
March 31, 2028
Enrollment
329 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory (r/r) angioimmunoblastic t-cell lymphoma (aitl), relapsed/refractory (r/r) mature b cell non hodgkin lymphoma (nhl)